SCHOLARLY PUBLICATION ✓ Open Access

NCCN Guidelines Insights: Breast Cancer, Version 1.2017

William John Gradishar, Benjamin O. Anderson, Ronald Balassanian, Sarah L. Blair, Harold J. Burstein, Amy E. Cyr, ANTHONY D. ELIAS, William Blair Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Philip Goetz, Lori J. Goldstein, Steven Jay Isakoff, Janice A. Lyons, Paul Kelly Marcom, Ingrid A. Mayer, Beryl L. McCormick, Meena S. Moran, Ruth M O'Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Kilian Elizabeth Salerno, Lee Steven Schwartzberg, Amy M. Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Hussein Soliman, George Somlo, Melinda L. Telli

📖 Journal of the National Comprehensive Cancer Network → 📅 2017-04-01 🔗 DOI: 10.6004/jnccn.2017.0044

View Journal Profile → ⬇ Download PDF View Official Paper ↗

📄 Abstract

These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.

ℹ️ Publication Details

Journal: Journal of the National Comprehensive Cancer Network
Published: 2017-04-01
DOI: 10.6004/jnccn.2017.0044
OpenAlex: W2609928112
Access: ✓ Open Access

📄 Abstract

📤 Share this page

🔬 Related Research Papers

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology

Role of Immunotherapy in Triple-Negative Breast Cancer

Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018